The three-dimensional structure of chromatin is crucial for the regulation of gene expression. YY1 promotes enhancer-promoter interactions in a manner analogous to CTCF-mediated chromatin interactions. However, little is known about which YY1 binding sites can form loop anchors. In this study, the LightGBM model was used to predict YY1-loop anchors by integrating multi-omics data. Due to the large imbalance in the number of positive and negative samples, we use AUPRC to reflect the quality of the classifier. The results show that the LightGBM model exhibits strong predictive performance (AUPRC≥0.93). To verify the robustness of the model, the dataset was divided into training and testing sets at a 4:1 ratio. The results show that the model performs well for YY1-loop anchor prediction on both the training and independent testing sets. Additionally, we ranked the importance of the features and found that the formation of YY1-loop anchors is primarily influenced by the co-binding of transcription factors CTCF, SMC3, and RAD21, as well as histone modifications and sequence context.

RNA interference (RNAi) has been widely utilized to investigate gene functions and has significant potential for control of pest insects. However, recent studies have revealed that the target insect species, dsRNA molecule length, target genes, and other experimental factors can affect the efficiency of RNAi mediated control, restricting the further development and application of this technology. Therefore, the aim of this study was to establish a deep learning model using bioinformatics to help researchers identify dsRNA fragments with the highest RNAi efficiency. In this study, we optimized an existing model, namely, dsRNAPredictor, by designing sub-models based on different sequence lengths. Accordingly, the data were divided into two groups: 130–399 bp and 400–616 bp long sequences. Then, one-hot encoding was employed to extract sequence information. The convolutional neural network framework comprising three convolutional layers, three average pooling layers, a flattened layer, and three dense layers was employed as the classifier. By adjusting the parameters, we established two sub-models for different sequence distributions. Using multiple independent test datasets and conducting hypothesis testing, we demonstrated that our model exhibits superior performance and strong robustness to dsRNAPredictor, respectively. Therefore, our model may help design dsRNAs with pre-screening potential and facilitate further research and applications.

Diabetes management is often complicated by comorbidities, requiring complex medication regimens that increase the risk of drug-drug interactions (DDIs), potentially compromising treatment outcomes or causing toxicity. Although machine learning (ML) models have made strides in DDI prediction, existing approaches lack specificity for oral diabetes medications and face challenges in interpretability. To address these limitations, we propose a novel ML-based framework utilizing the Simplified Molecular Input Line Entry System (SMILES) to encode structural information of oral diabetes drugs. Using this representation, we developed an XGBoost model, selecting molecular features through LASSO. Our dataset, sourced from DrugBank, included 42 oral diabetes drugs and 1,884 interacting drugs, divided into training, validation, and testing sets. The model identified 606 optimal features, achieving an F1-score of 0.8182. SHAP analysis was employed for feature interpretation, enhancing model transparency and clinical relevance. By predicting adverse DDIs, our model offers a valuable tool for clinical decision-making, aiding safer prescription practices. The 606 critical features provide insights into atomic-level interactions, linking computational predictions with biological experiments. We present a classification model specifically designed for predicting DDIs associated with oral diabetes medications, with an openly accessible web application to support diabetes management in multi-drug regimens and comorbidity settings.

Recent developments in spatial transcriptomics (ST) technology have markedly enhanced the proposed capacity to comprehensively characterize gene expression patterns within tissue microenvironments while crucially preserving spatial context. However, the identification of spatial domains at the single-cell level remains a significant challenge in elucidating biological processes. To address this, SpaInGNN was developed, a sophisticated graph neural network (GNN) framework that accurately delineates spatial domains by integrating spatial location data, histological information, and gene expression profiles into low-dimensional latent embeddings. Additionally, to fully leverage spatial coordinate data, spatial integration using graph neural network (SpaInGNN) refines the graph constructed for spatial locations by incorporating both tissue image distance and Euclidean distance, following a pre-clustering of gene expression profiles. This refined graph is then embedded using a self-supervised GNN, which minimizes self-reconfiguration loss. By applying SpaInGNN to refined graphs across multiple consecutive tissue slices, this study mitigates the impact of batch effects in data analysis. The proposed method demonstrates substantial improvements in the accuracy of spatial domain recognition, providing a more faithful representation of the tissue organization in both mouse olfactory bulb and human lateral prefrontal cortex samples

Recent advancements in spatial transcriptomics sequencing technologies can not only provide gene expression within individual cells or cell clusters (spots) in a tissue but also pinpoint the exact location of this expression and generate detailed images of stained tissue sections, which offers invaluable insights into cell type identification and cell function exploration. However, effectively integratingthegene expression data, spatial location information, and tissue images from spatial transcriptomics data presents a significant challenge for computational methodsin cell classification. In this work, we propose MVCLST, a multi-view comparative learningmethod to analyze spatial transcriptomicsdata for accurate cell type classification. MVCLSTconstructs two views based on gene expression profiles, cell coordinates and image features. The multi-view method we proposed can significantly enhance the effectiveness of feature extraction while avoiding the impact of erroneous information in organizing image or gene expression data. The model employs four separate encoders to capture shared and unique features within each view. To ensure consistency and facilitate information exchange between the two views, MVCLST incorporates a contrastive learning loss function. The extracted shared and private features from both views are fused using corresponding decoders. Finally, the model utilizes the Leiden algorithm to clusterthe learned featuresfor cell type identification. Additionally, we establish a framework called MVCLST-CCFS for spatial transcriptomicsdata analysis based on MVCLST and consistent clustering. Our method achieves excellent results in clustering on human dorsolateral prefrontal cortex data and the mouse brain tissue data. Italso outperforms state-of-the-art techniques in the subsequent search for highly variable genes across cell types on the mouse olfactory bulbdata.

Individuals with Post COVID-19 condition (PCC), or long COVID, experience symptoms such as fatigue, muscle weakness, and psychological distress, including anxiety, depression, or sleep disorders that persist after recovery from COVID-19. These ongoing symptoms significantly compromise quality of life and diminish functional capacity and independence. Multimodal digital interventions targeting behavioural factors such as nutrition and mindfulness have shown promise in improving health outcomes of people with chronic health conditions and may be beneficial for those with PCC. The BLEND study (weB-based pLatform to improve nutrition, mindfulnEss, and physical function, in patients with loNg COVID) study is an 8-week pilot randomized controlled trial evaluating the feasibility of a digital wellness platform compared to usual care among individuals with PCC. The web-based wellness platform employed in this study, My Viva Plan (MVP)®, integrates a holistic, multicomponent approach to promote wellness. The intervention group receives access to the digital health platform for 8 weeks with encouragement for frequent interactions to improve dietary intake and mindfulness. The control group receives general content focusing on improvements in dietary intake and mindfulness. Assessments are conducted at baseline and week 8. The primary outcome is the feasibility of platform use. Secondary and exploratory outcomes include a between-group comparison of changes in body composition, nutritional status, quality of life, mindfulness, physical activity, and physical performance after 8 weeks. Findings of this study will inform the development of effective web-based wellness programs tailored for individuals with PCC to promote sustainable behavioural changes and improved health outcomes.

HLA-DRB1*04:01 is associated with numerous diseases, including sclerosis, arthritis, diabetes, and COVID-19, emphasizing the need to scan for binders in the antigens to develop immunotherapies and vaccines. Current prediction methods are often limited by their reliance on the small datasets. This study presents HLA-DR4Pred2, developed on a large dataset containing 12,676 binders and an equal number of non-binders. It’s an improved version of HLA-DR4Pred, which was trained on a small dataset, containing 576 binders and an equal number of non-binders. All models were trained, optimized, and tested on 80 % of the data using five-fold cross-validation and evaluated on the remaining 20 %. A range of machine learning techniques was employed, achieving maximum AUROC of 0.90 and 0.87, using composition and binary profile features, respectively. The performance of the composition-based model increased to 0.93, when combined with BLAST search. Additionally, models developed on the realistic dataset containing 12,676 binders and 86,300 non-binders, achieved a maximum AUROC of 0.99. Our proposed method outperformed existing methods when we compared the performance of our best model to that of existing methods on the independent dataset. Finally, we developed a standalone tool and a webserver for HLADR4Pred2, enabling the prediction, design, and virtual scanning of HLA-DRB1*04:01 binding peptides, and we also released a Python package available on the Python Package Index (https://webs.iiitd.edu.in/raghava/hladr4pred2/; https://github.com/raghavagps/hladr4pred2; https://pypi.org/project/hladr4pred2/).

Although spatial transcriptomics data provide valuable insights into gene expression profiles and the spatial structure of tissues, most studies rely solely on gene expression information, underutilizing the spatial data. To fully leverage the potential of spatial transcriptomics and graph neural networks, the DGSI (Deep Graph Structure Infomax) model is proposed. This innovative graph data processing model uses graph convolutional neural networks and employs an unsupervised learning approach. It maximizes the mutual information between graph-level and node-level representations, emphasizing flexible sampling and aggregation of nodes and their neighbors. This effectively captures and incorporates local information from nodes into the overall graph structure. Additionally, this paper developed the DGSIST framework, an unsupervised cell clustering method that integrates the DGSI model, SVD dimensionality reduction algorithm, and k-means++ clustering algorithm. This aims to identify cell types accurately. DGSIST fully uses spatial transcriptomics data and outperforms existing methods in accuracy. Demonstrations of DGSIST’s capability across various tissue types and technological platforms have shown its effectiveness in accurately identifying spatial domains in multiple tissue sections. Compared to other spatial clustering methods, DGSIST excels in cell clustering and effectively eliminates batch effects without needing batch correction. DGSIST excels in spatial clustering analysis, spatial variation identification, and differential gene expression detection and directly applies to graph analysis tasks, such as node classification, link prediction, or graph clustering. Anticipation lies in the contribution of the DGSIST framework to a deeper understanding of the spatial organizational structures of diseases such as cancer.

The high dimensionality and noise challenges in genomic data make it difficult for traditional clustering methods. Existing multi-kernel clustering methods aim to improve the quality of the affinity matrix by learning a set of base kernels, thereby enhancing clustering performance. However, directly learning from the original base kernels presents challenges in handling errors and redundancies when dealing with high-dimensional data, and there is still a lack of feasible multi-kernel fusion strategies. To address these issues, we propose a Multi-Kernel Clustering method with Tensor fusion on Grassmann manifolds, called MKCTM. Specifically, we maximize the clustering consensus among base kernels by imposing tensor low-rank constraints to eliminate noise and redundancy. Unlike traditional kernel fusion approaches, our method fuses learned base kernels on the Grassmann manifold, resulting in a final consensus matrix for clustering. We integrate tensor learning and fusion processes into a unified optimization model and propose an effective iterative optimization algorithm for solving it. Experimental results on ten datasets, comparing against 12 popular baseline clustering methods, confirm the superiority of our approach. Our code is available at https://github.com/foureverfei/MKCTM.git.